Director Verduyn-van Weegen bought 1,562,500 shares of EVMN at $16.00 for $25,000,000; cluster pattern: 2 other insiders also bought within 14 days.
Director Felice Isabel Verduyn-van Weegen purchased 1,562,500 shares of Evommune at $16.00 on 2025-11-07, increasing her holdings to 4,929,633 shares (a +46.4% increase from 3,367,133 shares pre-transaction). The $25,000,000 transaction represents a substantial capital commitment by an insider during the company's recent listing phase (5 trading days since IPO). This purchase is part of a cluster buy pattern, with 2 other insiders also acquiring shares within the past 14 days, indicating coordinated or independently motivated insider accumulation. The current stock price of $19.52 as of 2025-11-12 is elevated relative to the $16.00 transaction price, though given the company's very recent listing status, longer-term trading patterns are not yet established. The presence of derivative holdings flagged in Table II warrants caution against interpreting the Table I position as the insider's total stake.